APOE and Alzheimer disease: Specifically, transient expression of APOE ε4 during the amyloid-seeding stage (days 7–14 of reprogramming) still increased Aβ oligomers and amyloidosis, suggesting that APOE ε4 has the greatest impact during the early phase of Aβ development in AD-patient-derived neurons.